Precigen, Inc. (PGEN)
NASDAQ: PGEN · Real-Time Price · USD
3.820
-0.070 (-1.80%)
At close: Sep 17, 2025, 4:00 PM EDT
3.840
+0.020 (0.52%)
After-hours: Sep 17, 2025, 5:01 PM EDT
Precigen Employees
Precigen had 143 employees as of December 31, 2024. The number of employees decreased by 59 or -29.21% compared to the previous year.
Employees
143
Change (1Y)
-59
Growth (1Y)
-29.21%
Revenue / Employee
$30,350
Profits / Employee
-$870,629
Market Cap
1.14B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 143 | -59 | -29.21% |
| Dec 31, 2023 | 202 | -7 | -3.35% |
| Dec 31, 2022 | 209 | -302 | -59.10% |
| Dec 31, 2021 | 511 | 34 | 7.13% |
| Dec 31, 2020 | 477 | -380 | -44.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PGEN News
- 14 days ago - Precigen Announces Up to $125 Million Non-Dilutive Financing - PRNewsWire
- 15 days ago - Precigen, Inc. - Special Call - Seeking Alpha
- 23 days ago - Precigen to Participate in Upcoming Virtual Fireside Chats Hosted by Cantor and H.C. Wainwright - PRNewsWire
- 26 days ago - Undercovered Dozen: Precigen, ONEOK, Bitmine And More - Seeking Alpha
- 4 weeks ago - Precigen: This Billion-Dollar Approval Is Still Undervalued - Seeking Alpha
- 4 weeks ago - Why Is Precigen Stock Surging On Friday? - Benzinga
- 4 weeks ago - US FDA approves Precigen's immunotherapy for rare respiratory disease - Reuters
- 4 weeks ago - Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis - PRNewsWire